Exemestane - anything new?

Perhaps she wants a bone scan or other tests before continuing your therapy. The docs are supposed to monitor for serious side effects and the new doc might not feel comfortable renewing until doing so. Some patients get switched to tamoxifen if their bones get too bad on an AI.

Readytorock, I myself would not stop taking my pills just because the insurance company and/or pharmacy said to; I would want to talk to the oncologist. They are probably looking at the typical standard of care, which is five years. However, as you may know, ER+ breast cancer can recur beyond the five-year mark, and ILC in particular may have a higher risk of late recurrence. I assume that this fact combined with your Oncotype score and your clinical risk as assessed by stage, grade, nodal status, and age (?) is the reason you were on the ten-year plan. The Breast Cancer Index is a test that uses your original tissue specimen from your biopsy or surgery to predict your benefit from extending endocrine therapy beyond five years. The hospital may have this tissue archived. If so, your doctor could order the test. Perhaps the new doctor just does not want to prescribe anything until he/she sees you. P.S. With ILC I would want to continue with an aromatase inhibitor and not tamoxifen, if possible. There is data to show it is more effective for ILC.